HIV/HBV Coinfection
CROI 2016: HIV/HBV Coinfection Linked to Worse Immune Recovery and Death
- Details
- Category: HIV/HBV Coinfection
- Published on Wednesday, 06 April 2016 00:00
- Written by Liz Highleyman
HIV-positive people with hepatitis B virus (HBV) coinfection had impaired CD4 cell recovery after starting antiretroviral (ART) and a higher risk of death than those without hepatitis B, but use of ART regimens containing tenofovir significantly reduced mortality, according to a study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2016)in Boston.
Coverage of the 2016 Conference on Retroviruses and Opportunistic Infections
- Details
- Category: HIV Treatment
- Published on Friday, 26 February 2016 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2016 Conference on Retroviruses and Opportunistic infections (CROI 2016), February 22-25, 2016, in Boston.
HIVandHepatitis.com coverage by topic
2/26/16
Antiretroviral Treatment for HIV Appears to Protect Gay Men Against Hepatitis B
- Details
- Category: HIV/HBV Coinfection
- Published on Monday, 19 October 2015 00:00
- Written by Liz Highleyman
HIV-positive gay and bisexual men who use effective combination antiretroviral therapy (ART) were 80% less likely to become infected with hepatitis B virus (HBV) in a large observational study reported in the October 13 Annals of Internal Medicine. The authors emphasize, however, that ART is not a substitute for hepatitis B vaccination.
Coverage of the 2015 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Monday, 23 November 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the 2015 American Association for the Study of Liver Diseases (AASLD) Liver Meeting in San Francisco, November 13-17, 2015.
Conference highlights include interferon-free therapy for hepatitis C, treatment for difficult-to-treat populations including people with HCV genotype 3 and liver cirrhosis, hepatitis B prevention and treatment, and management of advanced liver disease.
11/23/15
Tenofovir-containing Regimen Works Better Over Time for HIV/HBV Coinfected People
- Details
- Category: HIV/HBV Coinfection
- Published on Wednesday, 16 September 2015 00:00
- Written by Liz Highleyman
HIV-positive people coinfected with hepatitis B virus (HBV) who were treated with 2 dually-active drugs -- one of them being tenofovir -- responded about as well as people taking only lamivudine or emtricitabine at 24 weeks, but over the longer term those on tenofovir plus either lamivudine or emtricitabine were more likely to maintain undetectable HBV viral load, according to a study published in a recent edition of AIDS.
Web Design and Development by